# name
What do we know about Immunity to SARS-CoV-2? Implications for Public Health Policies

# metadata.dc.description[].value
Additional support from ISGlobal’s Antoni Plasència and Josep M. Antó

# metadata.dc.description.abstract[].value
As the COVID-19 pandemic progresses, so does our knowledge of the magnitude, type and durability of the immune response to SARS-CoV-2 as a result of natural infection or vaccination. This information is crucial since it will largely define the strategies we need to implement in order to protect individuals and populations. With this in mind, the GCMSC presents its second report, where they review the current knowledge on immunity to SARS-CoV-2 and the implications in terms of public health policies.

# metadata.dc.publisher[].value
Institut de Salut Global de Barcelona (ISGlobal)

# metadata.dc.publisher[].value
Col·legi Oficial de Metges de Barcelona (COMB)

# metadata.dc.rights[].value
cc-by (c) Multidisciplinary Collaborative Group for the Scientific Monitoring of COVID-19 (GCMSC), 2021

# metadata.dc.source[].value
Documents de treball / Informes (ISGlobal)

# metadata.dc.title[].value
What do we know about Immunity to SARS-CoV-2? Implications for Public Health Policies